Trial Outcomes & Findings for Study of Low Level Laser Light Therapy on Circumference Reduction (NCT NCT02109107)

NCT ID: NCT02109107

Last Updated: 2016-02-02

Results Overview

Combined circumference measurement is calculated as the sum of the measurements for the individual body areas of the right and left thighs, hips, waist and upper abdomen. Change in combined circumference measurements is calculated as the difference in measurements from baseline to after completion of the 6-week procedure administration period. A negative (-) change indicates a reduction in combined circumference measurement across the evaluation period and is positive for study success. A positive (+) change indicates an increase in combined circumference measurements across the evaluation period and is negative for study success. A mean change for the study subject group of -3.0 inches or more in combined circumference measurements will be considered a clinically meaningful and statistically significant positive change indicative of study success.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

54 participants

Primary outcome timeframe

Baseline and 6 weeks

Results posted on

2016-02-02

Participant Flow

Participant milestones

Participant milestones
Measure
Erchonia® Zerona 6 Headed Scanner (EZ6) Laser
The Erchonia® Zerona 6 Headed Scanner (EZ6) Laser is a 6 headed scanner composed of 6 independent 17 milliWatts (mW), 635 nanometer (nm) red laser diodes mounted in scanner devices. It is a variable frequency, pulsed wave laser device. Erchonia EZ6 Laser: The Erchonia EZ6 is administered 6 times across 6 consecutive weeks, each administration seven days apart, each treatment lasting 60 minutes.
Overall Study
STARTED
54
Overall Study
COMPLETED
52
Overall Study
NOT COMPLETED
2

Reasons for withdrawal

Reasons for withdrawal
Measure
Erchonia® Zerona 6 Headed Scanner (EZ6) Laser
The Erchonia® Zerona 6 Headed Scanner (EZ6) Laser is a 6 headed scanner composed of 6 independent 17 milliWatts (mW), 635 nanometer (nm) red laser diodes mounted in scanner devices. It is a variable frequency, pulsed wave laser device. Erchonia EZ6 Laser: The Erchonia EZ6 is administered 6 times across 6 consecutive weeks, each administration seven days apart, each treatment lasting 60 minutes.
Overall Study
Lost to Follow-up
2

Baseline Characteristics

Study of Low Level Laser Light Therapy on Circumference Reduction

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Erchonia EZ6 Laser
n=54 Participants
The Erchonia EZ6 Laser is a 6 headed scanner composed of 6 independent 17 milliWatts (mW), 635 nanometer (nm) red laser diodes mounted in scanner devices. It is a variable frequency, pulsed wave laser device. Erchonia EZ6 Laser: The Erchonia EZ6 is administered 6 times across 6 consecutive weeks, each administration seven days apart, each treatment lasting 60 minutes.
Age, Continuous
46.39 years
STANDARD_DEVIATION 9.83 • n=99 Participants
Sex: Female, Male
Female
51 Participants
n=99 Participants
Sex: Female, Male
Male
3 Participants
n=99 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=99 Participants
Race (NIH/OMB)
Asian
1 Participants
n=99 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=99 Participants
Race (NIH/OMB)
Black or African American
4 Participants
n=99 Participants
Race (NIH/OMB)
White
49 Participants
n=99 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=99 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=99 Participants
Region of Enrollment
United States
54 participants
n=99 Participants

PRIMARY outcome

Timeframe: Baseline and 6 weeks

Combined circumference measurement is calculated as the sum of the measurements for the individual body areas of the right and left thighs, hips, waist and upper abdomen. Change in combined circumference measurements is calculated as the difference in measurements from baseline to after completion of the 6-week procedure administration period. A negative (-) change indicates a reduction in combined circumference measurement across the evaluation period and is positive for study success. A positive (+) change indicates an increase in combined circumference measurements across the evaluation period and is negative for study success. A mean change for the study subject group of -3.0 inches or more in combined circumference measurements will be considered a clinically meaningful and statistically significant positive change indicative of study success.

Outcome measures

Outcome measures
Measure
Erchonia EZ6 Laser
n=54 Participants
The Erchonia EZ6 Laser is a 6 headed scanner composed of 6 independent 17 milliWatts (mW), 635 nanometer (nm) red laser diodes mounted in scanner devices. It is a variable frequency, pulsed wave laser device. Erchonia EZ6 Laser: The Erchonia EZ6 is administered 6 times across 6 consecutive weeks, each administration seven days apart, each treatment lasting 60 minutes.
Change in Combined Circumference Measurements
-5.36 inches
Standard Deviation 1.85

SECONDARY outcome

Timeframe: Baseline and 6 weeks

Body weight was measured in pounds at each evaluation point. The change in body weight measured in pounds at 6 weeks post-procedure administration relative to baseline was calculated. An increase in body weight indicated that weight was gained across the study evaluation period while a decrease in body weight indicated that weight was lost across the study evaluation period.

Outcome measures

Outcome measures
Measure
Erchonia EZ6 Laser
n=54 Participants
The Erchonia EZ6 Laser is a 6 headed scanner composed of 6 independent 17 milliWatts (mW), 635 nanometer (nm) red laser diodes mounted in scanner devices. It is a variable frequency, pulsed wave laser device. Erchonia EZ6 Laser: The Erchonia EZ6 is administered 6 times across 6 consecutive weeks, each administration seven days apart, each treatment lasting 60 minutes.
Change in Body Weight
-1.40 pounds
Standard Deviation 0.85

SECONDARY outcome

Timeframe: Baseline and 6 weeks

Body mass index (BMI) was measured in kilograms per meter squared (kg/m2) at each evaluation point. The change in BMI measured at 6 weeks post-procedure administration relative to baseline was calculated. An increase in BMI indicated that BMI increased across the study evaluation period which is negative for study success, while a decrease in BMI indicated that BMI decreased across the study evaluation period which is positive for study success.

Outcome measures

Outcome measures
Measure
Erchonia EZ6 Laser
n=54 Participants
The Erchonia EZ6 Laser is a 6 headed scanner composed of 6 independent 17 milliWatts (mW), 635 nanometer (nm) red laser diodes mounted in scanner devices. It is a variable frequency, pulsed wave laser device. Erchonia EZ6 Laser: The Erchonia EZ6 is administered 6 times across 6 consecutive weeks, each administration seven days apart, each treatment lasting 60 minutes.
Change in Body Mass Index (BMI)
-0.28 kg/m2
Standard Deviation 0.11

SECONDARY outcome

Timeframe: 6 weeks

At the end of the study procedure administration phase, the subject was asked to indicate how satisfied or dissatisfied they were with any change noticed in the appearance of the thighs, hips, waist and upper abdomen area after having received the procedures with the EZ6?", using the following five-point scale: Very Satisfied; Somewhat Satisfied; Neither Satisfied nor Dissatisfied; Not Very Satisfied; Not at All Satisfied

Outcome measures

Outcome measures
Measure
Erchonia EZ6 Laser
n=52 Participants
The Erchonia EZ6 Laser is a 6 headed scanner composed of 6 independent 17 milliWatts (mW), 635 nanometer (nm) red laser diodes mounted in scanner devices. It is a variable frequency, pulsed wave laser device. Erchonia EZ6 Laser: The Erchonia EZ6 is administered 6 times across 6 consecutive weeks, each administration seven days apart, each treatment lasting 60 minutes.
Subject Satisfaction With Study Outcome Rating
Very Satisfied
28 participants
Subject Satisfaction With Study Outcome Rating
Somewhat Satisfied
14 participants
Subject Satisfaction With Study Outcome Rating
Neither Satisfied Nor Dissatisfied
4 participants
Subject Satisfaction With Study Outcome Rating
Not Very Satisfied
3 participants
Subject Satisfaction With Study Outcome Rating
Not At All Satisfied
3 participants

Adverse Events

Erchonia EZ6 Laser

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Elvira Walls, Clinical Consultant

Regulatory Insight, Inc.

Phone: 615-712-9743

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place